RIPK2 and triple-negative breast carcinoma: Importantly, reconstituted RIP2 expression (pcDNA4 Omni-RIP2) largely restored migratory ability in all three triple-negative breast cancer cell lines (Figure 4B-E), indicating that the migration deficiency is unlikely to be an off-target effect of our siRNAs and that RIP2 has a clear role in migration.